TCG Crossover GP II, LLC 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-03 4:08 pm Purchase | 2024-12-27 | 13G | RAPT Therapeutics, Inc. RAPT | TCG Crossover GP II, LLC | 13,193,110 9.990% | 13,193,110 (New Position) | Filing |